Ether addiction
Addiction to consuming diethyl ether
Addiction to ether consumption, or etheromania, is the addiction to the inhalation or drinking of diethyl ether, commonly called "ether". Studies, including that of an ether addict in 2003, have shown that ether causes addiction; however, the only symptom observed was a will to consume more ether.
Nº Q5403301 ★★
Uncommon · History
Ether addiction
Addiction to consuming diethyl ether
Addiction to ether consumption, or etheromania, is the addiction to the inhalation or drinking of diethyl ether, commonly called "ether". Studies, including that of an ether addict in 2003, have shown that ether causes addiction; however, the only symptom observed was a will to consume more ether.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
Addiction to ether consumption, or etheromania, is the addiction to the inhalation or drinking of diethyl ether, commonly called "ether". Studies, including that of an ether addict in 2003, have shown that ether causes addiction; however, the only symptom observed was a will to consume more ether. No withdrawal symptoms were prevalent.
Text: Wikipédia, CC BY-SA 4.0. · Image: Grzegorz Barna (Public domain) ·
Related cards
Ethanol
Chemical compound
Nº Q153 ★★★★★
Compound spirit of ether
Chemical solution used for pain relief
Nº Q1171125 ★★
Alcohol abuse
Substance abuse that involves the recurring use of alcoholic beverages despite negative consequences
Nº Q7331102 ★★
Alcohol dependence
Human disease
Nº Q4713263 ★
Alcohol (drug)
Active ingredient in alcoholic beverages
Nº Q47146337 ★★★
Antidepressant discontinuation syndrome
Condition that can occur following the interruption, dose reduction, or discontinuation of antidepressant drugs, including selective serotonin re-uptake inhibitors (SSRIs) or serotonin–norepinephrine reuptake inhibitors (SNRIs)
Nº Q175918 ★★★